Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anhui Huanqiu Pharmaceutical is a Chinese pharmaceutical company headquartered in Bengbu, Anhui Province, that specializes in the research, development, and manufacturing of chemical drugs. The company is a prominent manufacturer of anti-infective medications, particularly fluoroquinolones such as levofloxacin and gatifloxacin, which are distributed under the 'Huanqiu' brand. In addition to its infectious disease portfolio, the company produces cardiovascular and respiratory treatments, including telmisartan. Operating as a national high-tech enterprise, it maintains multiple GMP-certified production lines for tablets, capsules, and large-volume injections. Anhui Huanqiu Pharmaceutical serves both the domestic Chinese market and international regions through its integrated manufacturing and distribution network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anhui Huanqiu Pharmaceutical.